Skip to main content

HPS Network supports conference on experimental lung disease research

Contact: Donna Appell, President and Founder, HPS Network, (516) 922-4022 or e-mail: dappell@hpsnetwork.org.

Date: Aug. 8, 2010

FOR IMMEDIATE RELEASE

HPS Network supports conference on experimental lung disease research

Oyster Bay, NY – The Hermansky-Pudlak Syndrome Network is a platinum-level sponsor of “The Lung Epithelium in Health and Disease Conference” to be held Aug. 8 – 13, 2010 in Saxtons River, Vt. The conference is one of many held by the Federation of American Societies for Experimental Biology (FASEB).

The conference’s presenters include some of the nation’s leading researchers specializing in investigating the mechanisms of pulmonary fibrosis. The event is being organized by Dr. Michael Beers (who attended the 2010 HPS Network New York Conference), Dr. Rama Mallampalli and Dr. Barry Stripp. The agenda includes several presentations on Hermansky-Pudlak Syndrome. HPS researchers Dr. Susan Guttentag and Dr. Lisa Young will be presenting and participating in the conference.

The conference is an opportunity for researchers not only to present cutting-edge discoveries, but also to network and brainstorm about future avenues of research. Continuing Medical Education credits will be available for conference attendees.

“We are pleased to do what we can to support this event,” says Donna Appell, President and Founder of the HPS Network, “Our members are fighting hard to find a cure for pulmonary fibrosis. This is one way we can help the brilliant researchers who one day will find the answer.”

Hermansky-Pudlak Syndrome is a form of albinism that, in addition to decreased pigment in the skin, hair or eyes and visual impairment, also causes a bleeding disorder. About 15 to 30 percent of people with HPS experience a digestive problem much like Crohn’s disease. HPS subtypes 1, 2 and 4 also cause pulmonary fibrosis.

The HPS Network has promoted research and supported families affected by this syndrome for the past 17 years. The HPS Network maintains an informational Website, toll-free number where those affected can seek help, a patient registry an active online community and produces educational conferences for families in New York and Puerto Rico.

To learn more about the HPS Network visit: www.hpsnetwork.org.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria